TTFields (Optune Lua) for Mesothelioma: 18.2-Month STELLAR Survival
David Foster
June 9, 2026
Optune Lua delivers tumor treating fields for pleural mesothelioma. The STELLAR trial reported 18.2-month median survival. Here's the 2026 evidence and status.